Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02811445 · ClinicalTrials.gov registry record

Role of the Gut Microbiome on Lean Mass and Physical Function in Older Adults

A clinical trial of Sarcopenia, sponsored by Tufts University.

Completed
Registry status
29
Enrollment target
1
Study location

NCT02811445 is a study of Sarcopenia that has completed, run by Tufts University. The registered enrollment target is 29 participants, below the 80-participant average among 41 other Sarcopenia trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02811445, a study of Sarcopenia, has completed, sponsored by Tufts University.

COMPLETED
Registry status
29 participants
Enrollment target
1
Study location

Study Summary

The investigators recently published significant associations between circulating gut bacteria-related metabolites with lean and skeletal muscle mass and with measures of physical function in older adults, evidence that suggests a role for gut bacteria on the maintenance of these outcomes. To date, studies aimed at identification of associations between gut bacteria with lean mass or with specific measures of physical function have yet to be reported. Accordingly, the over-arching hypothesis is that gut bacteria are associated with, and are causatively involved in mechanisms that underlie the maintenance of lean mass and physical function in older adults. Results obtained from the proposed study are intended as the basis for future studies aimed at targeted modulation of the gut microflora, which may be a novel and innovative means for improving lean mass and physical function, and for addressing the public health priority of healthy aging in older adults.

Conditions Studied

Study Locations (1)

Massachusetts

  • Tufts University - Boston

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2016-05
Est. Completion 2019-11-01

Sponsor

Tufts University

163 total trials

What the Registry Record Tells You About NCT02811445

The ClinicalTrials.gov registry entry for NCT02811445 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 80-participant average among 41 other Sarcopenia trials with a reported enrollment target (64% lower). The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sarcopenia appearing as the primary indexed condition, and to 0 interventions.

NCT02811445 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02811445 about?

NCT02811445 is a clinical study titled "Role of the Gut Microbiome on Lean Mass and Physical Function in Older Adults". The investigators recently published significant associations between circulating gut bacteria-related metabolites with lean and skeletal muscle mass and with measures of physical function in older adults, evidence that suggests a role for gut bacteria on the maintenance of these outcomes. To date, ...

What is the current status of trial NCT02811445?

This trial is currently completed. The enrollment target is 29 participants. The study started on 2016-05. Estimated completion is 2019-11-01.

What conditions does trial NCT02811445 study?

This clinical trial studies the following conditions: Sarcopenia.

Who is sponsoring clinical trial NCT02811445?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02811445 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sarcopenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.